In thrombosis, platelet aggregation is initiated by a specific membrane gly
coprotein (GP) Ib-IX-V complex binding to its adhesive ligand, von Willebra
nd factor, in the matrix of ruptured atherosclerotic plaques or in plasma e
xposed to high hydrodynamic shear stress. This process closely resembles no
rmal haemostasis at high shear, where GP Ib-IX-V-dependent platelet adhesio
n to von Willebrand factor in the injured blood vessel wall initiates plate
let activation and integrin alpha IIb beta 3 (GP IIb-IIIa)-dependent platel
et aggregation. At low shear, other receptors such as those that bind colla
gen, the integrin alpha 2 beta 1 (GP Ia-IIa) or GP VI, mediate platelet adh
esion. Recently, snake venom proteins have been identified that selectively
modulate platelet function, either promoting or inhibiting platelet aggreg
ation by targeting GP Ib-IX-V, alpha 2 beta 1, GP VI, alpha IIb beta 3, or
their respective ligands. Interestingly, these venom proteins typically bel
ong to one of two major protein families, the C-type lectin family or the m
etalloproteinase-disintegrins. This review focuses on recent insights into
structure-activity relationships of snake venom proteins that regulate plat
elet function, and the ways in which these novel probes have contributed in
unexpected ways to our understanding of the molecular mechanisms underlyin
g thrombosis. (C) 2000 Elsevier Science Ltd. All rights reserved.